LIPIDRESCUE Trademark
Trademark Overview
On Thursday, July 7, 2022, a trademark application was filed for LIPIDRESCUE with the United States Patent and Trademark Office. The USPTO has given the LIPIDRESCUE trademark a serial number of 97492223. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, March 22, 2024. This trademark is owned by ResQ Pharma, Inc.. The LIPIDRESCUE trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe for administering the lipid emulsion, all for use in treating anesthetic and drug toxicity; Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe for administering the lipid emulsion, all for use in resuscitating patients; Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe for administering the lipid emulsion, all for use in treating cardiac arrest due to ischemia and cardiac failure; syringes that are used for administering lipid emulsions in the nature of syringes sold filled with a pharmaceutical, namely, a lipid emulsion for use in treating anesthetic and drug toxicity, treating neurological toxicity, treating cardia...
Medical services, namely, treating anesthetic toxicity, treating drug overdoses and poisoning, resuscitating patients suffering from the toxic side effects caused by anesthetics and unknown substances, treating cardiac toxins, administering lipid emulsions and other lipid containing substances to patients, and administering lipid emulsions to treat cardiac arrest due to ischemia, cardiac failure, and cardiac toxicity
General Information
| Serial Number | 97492223 |
| Word Mark | LIPIDRESCUE |
| Filing Date | Thursday, July 7, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Friday, March 22, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 29, 2023 |
Trademark Statements
| Goods and Services | Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe for administering the lipid emulsion, all for use in treating anesthetic and drug toxicity; Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe for administering the lipid emulsion, all for use in resuscitating patients; Medical kits consisting primarily of a pharmaceutical preparation in the nature of a lipid emulsion sold inside of a bag, and also including a medical syringe for administering the lipid emulsion, all for use in treating cardiac arrest due to ischemia and cardiac failure; syringes that are used for administering lipid emulsions in the nature of syringes sold filled with a pharmaceutical, namely, a lipid emulsion for use in treating anesthetic and drug toxicity, treating neurological toxicity, treating cardiac arrest due to ischemia, treating cardiac failure, treating cardiac toxicity, and for resuscitating patients |
| Pseudo Mark | LIPID RESCUE |
| Goods and Services | Medical services, namely, treating anesthetic toxicity, treating drug overdoses and poisoning, resuscitating patients suffering from the toxic side effects caused by anesthetics and unknown substances, treating cardiac toxins, administering lipid emulsions and other lipid containing substances to patients, and administering lipid emulsions to treat cardiac arrest due to ischemia, cardiac failure, and cardiac toxicity |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 26, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 26, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | ResQ Pharma, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Chicago, IL 60612 |
| Party Name | ResQ Pharma, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Chicago, IL 60612 |
Trademark Events
| Event Date | Event Description |
| Monday, April 10, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, July 11, 2022 | NEW APPLICATION ENTERED |
| Tuesday, July 26, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, February 27, 2023 | ASSIGNED TO EXAMINER |
| Monday, April 10, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, April 10, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, June 22, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 22, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 23, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 19, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, July 20, 2023 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Wednesday, July 26, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, July 26, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 26, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 26, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, July 26, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 29, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 9, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 29, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 24, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, March 22, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, March 22, 2024 | SOU EXTENSION 1 FILED |
| Friday, March 22, 2024 | SOU EXTENSION 1 GRANTED |
| Saturday, March 23, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
